FDA warns popular diabetes drug has cancer risk, seeks multiple recalls

In a statement this week, the Food and Drug Administration warned that its laboratory has discovered impurities in some batches of popular diabetes drug metformin that may be a cancer risk. The discovery involves “several lots” of the extended-release (ER) version of metformin, prompting the agency to seek voluntary drug recalls from five different companies. According to the release published … Continue reading